英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
realta查看　realta　在百度字典中的解释百度英翻中〔查看〕
realta查看　realta　在Google字典中的解释Google英翻中〔查看〕
realta查看　realta　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • ReAlta Life Sciences, Inc.
    ReAlta Life Sciences, a clinical stage company focused on rare diseases, has developed a novel class of drugs with unique dual-targeting therapeutic capabilities that rebalance complement and inflammatory processes
  • ReAlta Life Sciences Strengthens Board of Directors with Appointment of . . .
    New appointments bring deep research and development expertise and technology innovation to support continued advancement of ReAlta’s EPICC Technology Platform
  • ReAlta Life Sciences Strengthens Board of Directors with Appointment of . . .
    Norfolk, VA – January 3, 2024 – ReAlta Life Sciences, Inc (“ReAlta” or the “Company”), a mid-stage clinical biotech company dedicated to saving lives by rebalancing the inflammatory response to address life-threatening diseases, today announced the appointment of three seasoned biotechnology executives, Christi Shaw, Mert Aktar
  • ReAlta Life Sciences Announces New Inflammatory Biomarker Data from . . .
    ReAlta’s therapeutic peptides employ the dual-targeting mechanisms of HAstV-1 to modulate both complement and innate inflammatory pathways by inhibiting complement cascade activation and two key neutrophil-driven mechanisms: myeloperoxidase (MPO) and neutrophil extracellular traps (NETs)
  • Board of Directors - Realta Life Sciences
    ReAlta Life Sciences is a clinical stage biotech company, dedicated to saving lives by rebalancing the inflammatory response through our EPICC technology platform
  • About Us - Realta Life Sciences
    ReAlta Life Sciences is a clinical stage biotech company, dedicated to saving lives by rebalancing the inflammatory response through our EPICC technology platform
  • News about ReAlta Life Sciences
    ReAlta Life Sciences Announces New Clinical Data for RLS-0071 (pegtarazimod) from Hypoxic Data confirm elevated inflammatory biomarkers in newborns with Hypoxic Ischemic Encephalopathy (HIE) and demonstrate a predictable pharmacokinetic profile for RLS-0071
  • Management Team - Realta Life Sciences
    ReAlta Life Sciences is a clinical stage biotech company, dedicated to saving lives by rebalancing the inflammatory response through our EPICC technology platform
  • ReAlta Life Sciences Announces Appointment of Distinguished . . .
    ReAlta’s therapeutic peptides employ the dual-targeting mechanisms of HAstV-1 to modulate both complement and innate inflammatory pathways by inhibiting complement cascade activation and two key neutrophil-driven mechanisms: myeloperoxidase (MPO) and neutrophil extracellular traps (NETs)
  • ReAlta Life Sciences Announces New Clinical Data for RLS-0071 . . .
    ReAlta’s therapeutic peptides employ the dual-targeting mechanisms of HAstV-1 to modulate both complement and innate inflammatory pathways by inhibiting complement cascade activation and two key neutrophil-driven mechanisms: myeloperoxidase (MPO) and neutrophil extracellular traps (NETs)





中文字典-英文字典  2005-2009